Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurol Sci ; 370: 167-172, 2016 Nov 15.
Article in English | MEDLINE | ID: mdl-27772753

ABSTRACT

OBJECTIVES: We explored the role of oxidative stress and inflammatory molecules as potential Parkinson (PD) biomarkers and correlated biological with non-motor abnormalities (olfactory impairment and dysautonomia), in patients with idiopathic REM behavior disorder (iRBD) (prodromal PD) and established PD. METHODS: We recruited 11 iRBD and 15 patients with idiopathic PD (Hohen&Yahr 1-3, on L-DOPA and dopamine agonists combination therapy) and 12 age- and sex-matched controls (CTRL). We measured total olfactory score (TOS), autonomic function [deep breathing (DB), lying to standing (LS) and Valsalva manoeuvre (VM) ratios], blood reduced glutathione (Br-GSH), oxidative stress and inflammatory markers (neopterin). RESULTS: Anosmia was similarly prevalent in iRBD (36%) and PD (33%) patients, but absent in CTRL. Orthostatic hypotension was more common among iRBD (73%) and PD (60%) than in CTRL (25%). By univariable ordinal logistic regression, TOS, Br-GSH, LS and VM ratio worsened from CTRL to iRBD and PD groups. Only reduced Br-GSH levels (p=0.037, OR=0.994; 95%CI 0.988-1.000) were independently associated to PD. TOS correlated with Br-GSH (R=0.34, p=0.037), VM ratio (R=0.43, p=0.015), and neopterin (rho=0.39, p=0.016). CONCLUSIONS: Reduced systemic antioxidant capacity is found in prodromal and overt PD and may represent, in association with olfactory loss and cardiovascular dysautonomia, a useful biomarker for an integrative, early diagnosis of PD.


Subject(s)
Parkinson Disease/diagnosis , Parkinson Disease/metabolism , Aged , Antiparkinson Agents/therapeutic use , Biomarkers/metabolism , Dopamine Agonists/therapeutic use , Drug Therapy, Combination , Female , Glutathione/blood , Humans , Levodopa/therapeutic use , Logistic Models , Male , Middle Aged , Neopterin/urine , Parkinson Disease/drug therapy , Prodromal Symptoms , Smell , Valsalva Maneuver
2.
Stroke ; 37(5): 1184-8, 2006 May.
Article in English | MEDLINE | ID: mdl-16574924

ABSTRACT

BACKGROUND AND PURPOSE: Sympathetic hyperactivity is a contributing cause of vascular disorders because it increases blood pressure, blood sugar, and blood lipids. Pervasive compromise of the central and peripheral autonomic nervous systems is common in idiopathic Parkinson disease (IPD) resulting in reduced sympathetic and parasympathetic function. We hypothesized that IPD was associated with reduced prevalence of cardiovascular disease risk factors as a result of reduced sympathetic activity. METHODS: We performed a retrospective case-control study on 178 newly diagnosed consecutive IPD patients, and 533 age- (+/-3 years) and sex-matched controls with other neurological diseases seen over the same period at the same hospital. For each case and control the following were noted on admission: smoking, diabetes, hypertension, body mass index, serum glucose, plasma cholesterol, triglycerides and total lipid levels, and blood pressure. RESULTS: Diabetes, history of smoking, high blood pressure, high blood glucose, high blood cholesterol, and triglycerides were significantly less frequent in IPD than controls. CONCLUSIONS: IDP is a natural model of impaired hypothalamic-pituitary-adrenal axis activity and generalized sympathetic denervation. We interpret the association of untreated IPD with reduced vascular diseases risk factors as attributable to reduced autonomic activity, suggesting that autonomic hyperactivity may be involved in the pathogenesis of vascular disorders.


Subject(s)
Parkinson Disease , Sympathetic Nervous System/physiopathology , Vascular Diseases , Age Factors , Aged , Blood Glucose , Blood Pressure , Body Mass Index , Case-Control Studies , Cholesterol/blood , Diabetes Mellitus/physiopathology , Female , Humans , Hypothalamo-Hypophyseal System/physiopathology , Male , Middle Aged , Multivariate Analysis , Parkinson Disease/blood , Parkinson Disease/complications , Parkinson Disease/physiopathology , Retrospective Studies , Risk Factors , Sex Factors , Smoking , Triglycerides/blood , Vascular Diseases/blood , Vascular Diseases/etiology , Vascular Diseases/physiopathology
3.
J Neurol ; 250(4): 429-35, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12700907

ABSTRACT

OBJECTIVE: To identify correlations between clinical and neuroimaging features in sporadic chorea and to explicate the evolution of choreas of differing aetiologies. METHODS: We analysed the clinical and neuroimaging data of 51 consecutive cases (17 males, 34 females; age 16-95 years) of sporadic chorea admitted to the neurology departments of two general hospitals from January 1994 to December 1999, and two neurological institutes from January 1997. Six months later the patients were reassessed clinically and those still with chorea (20 cases) were asked to undergo the genetic tests for Huntington's disease and dentatorubropallidoluysian atrophy. RESULTS: There were 9 cases of focal dyskinesias, 18 of hemichorea, and 24 of generalised chorea; onset was acute in 17, subacute in 27, and insidious in seven. Analysis permitted classification as follows: vascular-related (21 cases); vasculitis (1 case); hypoxia (2 cases); drug-induced (7 cases); AIDS-related (5 cases), borreliosis (1 case); Sydenham's chorea (1 case); hyperglycaemia (2 cases); hyponatraemia (2 cases); Huntington's disease (HD) (5 cases) and acanthocytosis (1 case). In 3 patients neither etiological factors nor neuroradiological alterations were found. CONCLUSIONS: Although a convincing concordance between choreic signs and neuroradiological findings was possible in 4 patients only, it was possible to assign an aetiology in most cases with vascular related causes the most frequent and metabolic factors often participating. Huntington's disease is not unusual as a cause of sporadic choreas. HIV infection is an emerging cause of chorea and AIDS-related disease should be considered in young patients presenting without a family history of movement disorders. We emphasize the importance of follow-up to identify persistent chorea for which genetic testing is mandatory.


Subject(s)
Chorea/etiology , Chorea/pathology , HIV Infections/complications , Adolescent , Adult , Age of Onset , Aged , Aged, 80 and over , Cerebrovascular Disorders/complications , Chorea/genetics , Female , Genetic Testing , Humans , Huntington Disease/etiology , Huntington Disease/genetics , Huntington Disease/pathology , Male , Metabolic Diseases/complications , Middle Aged , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...